Verastem ($VSTM) Insider Trading & Smart Money Activity

Verastem, Inc. · Biotechnology · Latest filing Oct 1, 2026

Verastem, Inc. ($VSTM) has 5 insider trades, 2 13F position changes and 2 analyst ratings on file. In the last 12 months on the open market, no insider bought and 4 insiders sold ($478.25K), net -$478.25K.

Insider buyers (12 mo)
0
Insider sellers (12 mo)
4
Net insider $ (12 mo)
-$478.25K
Congress trades (12 mo)
0
13F moves on file
2
Analyst ratings on file
2

VSTM insider buying and selling by quarter

QuarterInsider buysInsider salesCongress buys / sales13F added / cut
Q1 2026 0 0 0 / 0 0 / 0
Q2 2026 0 2 · $104.33K 0 / 0 2 / 0
Q3 2026 0 1 · $423.50 0 / 0 0 / 0
Q4 2026 0 2 · $373.50K 0 / 0 0 / 0

Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.

All VSTM insider, congress, 13F and analyst activity

DateSourceWhoActionSharesValue / amount ΔOwn1W1M6MFilingStory
Insider Paterson DanPresident and CEO Sell (Open-market sale) 10b5-1 44.12K sh $352.97K +2.7% —
Insider Calkins DanielChief Financial Officer Sell (Open-market sale) 10b5-1 2.57K sh $20.53K +2.7% —
Insider Calkins DanielChief Financial Officer Sell (Open-market sale) 10b5-1 55 sh $423.50 -2.8% —
Analyst BTIG Reiterates to buy PT $18 +6.5%+57.1% Read
Analyst Jefferies Reiterates to buy PT $8 -9.3%+46.8% Read
Insider Dan PatersonPresident and CEO Sell (Open-market sale) 10b5-1 20.87K sh $87.24K -10.1%+38.6% —
Insider Daniel CalkinsChief Financial Officer Sell (Open-market sale) 10b5-1 4.09K sh $17.09K -10.1%+38.6% Read
13F Baker Bros. Advisors New +584.76K sh $2.40M -1.9%-7.4% —
13F Baker Bros. Advisors New +584.76K sh $2.23M -1.9%-7.4% Read

1W / 1M / 6M = how VSTM moved from the trade or filing date.

Insider trading in VSTM: who is buying and selling

InsiderRoleTradesOpen-market netShares heldLast trade
Calkins Daniel Chief Financial Officer 2 -$20.95K Oct 1, 2026
Paterson Dan President and CEO 1 -$352.97K Oct 1, 2026
Dan Paterson President and CEO 1 -$87.24K Jun 22, 2026
Daniel Calkins Chief Financial Officer 1 -$17.09K Jun 22, 2026

Institutions moving VSTM (13F)

Analyst ratings on VSTM

DateFirmActionRatingPrice target1W1M6MStory
BTIG Reiterates buy $18 +6.5%+57.1% Read
Jefferies Reiterates buy $8 -9.3%+46.8% Read

Frequently asked questions

Are VSTM insiders buying or selling?

Over the last 12 months 0 insiders made 0 open-market purchases worth $0 and 4 insiders made 5 open-market sales worth $478.25K, a net -$478.25K.

What is the latest insider trade in VSTM?

Paterson Dan, President and CEO filed a sell (open-market sale) of 44.12K sh worth $352.97K on Oct 1, 2026.

Which institutions changed their VSTM positions?

Recent 13F filers moving the stock include Baker Bros. Advisors.

Other biotechnology stocks

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.

Get trade alerts by text